Ratio Therapeutics Raises $70m in Series C for Cancer Radiotherapy Push
Funding will advance clinical trials for its lead radiopharmaceutical candidate targeting advanced sarcomas and expand pipeline development. Ratio Therapeutics, a clinical-stage radiopharmaceutical developer, has secured $70m in Series C financing. The round included exist